St. James Investment Company LLC Trims Holdings in Corteva, Inc. $CTVA

St. James Investment Company LLC trimmed its position in Corteva, Inc. (NYSE:CTVA) by 23.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 225,675 shares of the company’s stock after selling 70,533 shares during the period. Corteva comprises about 2.4% of St. James Investment Company LLC’s investment portfolio, making the stock its 18th largest position. St. James Investment Company LLC’s holdings in Corteva were worth $15,127,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Perpetual Ltd lifted its holdings in Corteva by 78,688.5% in the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after purchasing an additional 2,612,459 shares in the last quarter. Amundi lifted its holdings in Corteva by 125.3% in the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after purchasing an additional 1,899,248 shares in the last quarter. Squarepoint Ops LLC lifted its holdings in Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares in the last quarter. Man Group plc lifted its holdings in shares of Corteva by 16,474.3% during the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after acquiring an additional 1,286,317 shares during the period. Finally, State Street Corp lifted its holdings in shares of Corteva by 3.6% during the 3rd quarter. State Street Corp now owns 35,280,805 shares of the company’s stock worth $2,386,041,000 after acquiring an additional 1,230,074 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. BNP Paribas Exane increased their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Argus increased their price objective on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Rothschild & Co Redburn increased their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Oppenheimer increased their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Thirteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, Corteva has an average rating of “Moderate Buy” and an average target price of $87.52.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.15% of the company’s stock.

Corteva Stock Down 0.3%

CTVA opened at $82.59 on Wednesday. The firm has a 50 day moving average price of $80.88 and a 200 day moving average price of $73.03. The company has a market cap of $55.24 billion, a PE ratio of 48.58, a price-to-earnings-growth ratio of 2.68 and a beta of 0.59. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.7 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.